Delivery Order SPE2DB20D2014-SPE2DB24FB08L
- Not listed
- This federal contract award, valued at $2,014.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,504.80, is for the delivery of pharmaceutical products, including the drug ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $17,699.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for a delivery order of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of March 7, 2024. The contract type is Firm Fixed Price. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,207.12 delivery order contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a period of performance through February 13, 2024 and uses a firm fixed price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $47,564.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed price for the supply of 4563226596 - ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 4, 2024 and was awarded on January 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,360.80 delivery order is for the medical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" and has a period of performance through February 27, 2024. The contract is a firm fixed price delivery order, indicating the government procured a specific quantity of the product at a pre-determined price. This award is not associated with a set-aside...
- This federal contract award, valued at $2,108.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML", a medical product, with a completion date of November 27, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,160.45 firm fixed price delivery order is for ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a medical product. The contract has an ultimate completion date of July 11, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This federal contract award, valued at $5,197.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including the medication ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
- This federal contract award, valued at $12,458.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military treatment programs and facilities worldwide. The award has an ultimate completion date of August 9, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with both the DLA Troop Support...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB08LDelivery Order
This federal contract award, valued at $25,222.68, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563664766 ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The current award is not designated as a set-aside contract. Amerisourcebergen Drug Corp also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.2k | 2/14/24 |